SI2906233T1 - Farmacevtske oblike za zdravljenje in preventivo debelosti - Google Patents

Farmacevtske oblike za zdravljenje in preventivo debelosti Download PDF

Info

Publication number
SI2906233T1
SI2906233T1 SI201330937T SI201330937T SI2906233T1 SI 2906233 T1 SI2906233 T1 SI 2906233T1 SI 201330937 T SI201330937 T SI 201330937T SI 201330937 T SI201330937 T SI 201330937T SI 2906233 T1 SI2906233 T1 SI 2906233T1
Authority
SI
Slovenia
Prior art keywords
extract
compositions according
obesity
treatment
panax ginseng
Prior art date
Application number
SI201330937T
Other languages
English (en)
Inventor
Ezio Bombardelli
Fabrizio Corti
Original Assignee
Indena S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena S.P.A. filed Critical Indena S.P.A.
Publication of SI2906233T1 publication Critical patent/SI2906233T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/85—Verbenaceae (Verbena family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Claims (8)

  1. NASLOV: Farmacevtske oblike za zdravljenje in preventivo debelosti PATENTNI ZAHTEVKU.
    1. Sestavki, ki obsegajo: a) ekstrakt Phaseolus vulgaris; b) ekstrakt Cynara scolymus; c) ekstrakt Echinacea angustifolia; d) ekstrakt Vitis vinifera; in opcijsko e) ekstrakt Panax ginseng, v zmesi s primernimi pomožnimi snovmi.
  2. 2. Sestavki po zahtevku 1 v obliki tablet, zrnc, mehkih ali trdih želatinskih kapsul ali celuloznih kapsul.
  3. 3. Sestavki po katerem koli izmed zahtevkov 1 in 2, kjer ima ekstrakt Phaseolus vulgaris vsebnost inhibitorja a-amilaze 300 pg/mg in lecitinsko vrednost 10.000 U/mg.
  4. 4. Sestavki po enem ali več izmed zahtevkov 1 do 3, kjer ima ekstrakt Cynara scolymus vsebnost kafeoilkininske kisline v območju od 20 do 70%, prednostno 35%.
  5. 5. Sestavki po enem ali več izmed zahtevkov 1 do 4, kjer ima ekstrakt Panax ginseng vsebnost ginsenozida 7%, določeno s HPLC.
  6. 6. Sestavki po enem ali več izmed zahtevkov 1 do 5, ki vsebujejo 100 mg ekstrakta Phaseolus vulgaris, 50 do 200 mg ekstrakta Cynara scolymus, 25 mg ekstrakta Echinacea angustifolia in 200 mg ekstrakta pešk Vitis vinifera.
  7. 7. Sestavki po zahtevku 6, ki vsebujejo tudi 40 mg ekstrakta Panax ginseng,
  8. 8. Sestavki po zahtevkih 1-7 za uporabo pri zdravljenju debelosti in prekomerne telesne teže.
SI201330937T 2012-10-12 2013-10-10 Farmacevtske oblike za zdravljenje in preventivo debelosti SI2906233T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT001727A ITMI20121727A1 (it) 2012-10-12 2012-10-12 Formulazioni per il trattamento e la prevenzione dell'obesita'
PCT/EP2013/071138 WO2014057024A1 (en) 2012-10-12 2013-10-10 Formulations for the treatment and prevention of obesity
EP13786434.4A EP2906233B1 (en) 2012-10-12 2013-10-10 Formulations for the treatment and prevention of obesity

Publications (1)

Publication Number Publication Date
SI2906233T1 true SI2906233T1 (sl) 2018-03-30

Family

ID=47278416

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201330937T SI2906233T1 (sl) 2012-10-12 2013-10-10 Farmacevtske oblike za zdravljenje in preventivo debelosti

Country Status (23)

Country Link
US (2) US9901610B2 (sl)
EP (1) EP2906233B1 (sl)
JP (1) JP6324391B2 (sl)
KR (1) KR102143990B1 (sl)
CN (1) CN104703616A (sl)
AU (1) AU2013328716B2 (sl)
BR (1) BR112015007896B1 (sl)
CA (1) CA2887831A1 (sl)
DK (1) DK2906233T3 (sl)
ES (1) ES2657892T3 (sl)
HK (1) HK1211221A1 (sl)
HU (1) HUE036454T2 (sl)
IL (1) IL238126B (sl)
IN (1) IN2015DN02944A (sl)
IT (1) ITMI20121727A1 (sl)
NO (1) NO2906233T3 (sl)
PL (1) PL2906233T3 (sl)
PT (1) PT2906233T (sl)
RU (1) RU2646459C2 (sl)
SG (1) SG11201502781PA (sl)
SI (1) SI2906233T1 (sl)
TR (1) TR201802570T4 (sl)
WO (1) WO2014057024A1 (sl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE202014005450U1 (de) * 2014-07-04 2015-10-06 Ursapharm Arzneimittel Gmbh Lactosefreies Arzneimittel
JP2017025171A (ja) * 2015-07-17 2017-02-02 三栄源エフ・エフ・アイ株式会社 タブレット状可食性組成物
ITUB20156036A1 (it) * 2015-11-30 2017-05-30 Indena Spa Estratti di echinacea angustifolia e zanthoxylum bungeanum per la prevenzione e/o il trattamento dell?obesita e del sovrappeso
CN106770832B (zh) * 2017-01-05 2019-03-29 中国人民解放军第一五九医院 参茸益精片质量控制方法
CN108498563B (zh) * 2018-05-18 2020-10-23 广东药科大学 一种壳聚糖组合物及其制备方法
CN110433280A (zh) * 2019-09-11 2019-11-12 周口师范学院 植物血凝素在制备预防或治疗肥胖药物中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1574806A (en) * 1976-06-03 1980-09-10 Inverni Della Beffa Spa Production of purified ginseng extracts and pharmaceutical compositions containing the extracts
US5484594A (en) 1988-06-28 1996-01-16 Tecnofarmaci S.P.A. Process for preparing grapeseed extracts enriched in procyanidol oligomers
DE19627376A1 (de) * 1996-07-06 1998-01-08 Aar Pharma Adler Apotheke Verwendung von Artischocken-(Cynara)-Extrakten
DE19639375A1 (de) * 1996-09-25 1998-04-02 Aar Pharma Mistel-Trockenextrakte
AUPO990397A0 (en) * 1997-10-22 1997-11-13 R.P. Scherer Holdings Pty Ltd Clear solutions of herbal extracts
ITMI20021691A1 (it) 2002-07-30 2004-01-30 Indena Spa Estratti di echinacea angustifolia
ITMI20051347A1 (it) * 2005-07-14 2007-01-15 Indena Spa Estratti di cynara scolimus loro uso e formulazioni che li contengono
CN100556429C (zh) * 2005-09-05 2009-11-04 郭爱华 一种含有葡萄提取物的药物组合物及其制备方法、用途
ITMI20052450A1 (it) * 2005-12-22 2007-06-23 Indena Spa Estratti di phaseolus vulgaris loro uso e formulazioni che li contengono
ATE431155T1 (de) * 2007-03-07 2009-05-15 Indena Spa Formulierungen mit extrakten aus cynara scolymus und phaseolus vulgaris zur behandlung von adipositas
CN104039128A (zh) * 2011-11-14 2014-09-10 株式会社富永树脂工业所 小动物饲养容器

Also Published As

Publication number Publication date
EP2906233A1 (en) 2015-08-19
ES2657892T3 (es) 2018-03-07
HK1211221A1 (en) 2016-05-20
US9901610B2 (en) 2018-02-27
AU2013328716B2 (en) 2017-08-03
JP6324391B2 (ja) 2018-05-16
IL238126B (en) 2019-07-31
ITMI20121727A1 (it) 2014-04-13
KR102143990B1 (ko) 2020-08-13
PL2906233T3 (pl) 2018-05-30
RU2015112879A (ru) 2016-12-10
DK2906233T3 (da) 2018-01-29
HUE036454T2 (hu) 2018-07-30
JP2015533138A (ja) 2015-11-19
IN2015DN02944A (sl) 2015-09-18
TR201802570T4 (tr) 2018-03-21
NO2906233T3 (sl) 2018-04-28
EP2906233B1 (en) 2017-11-29
SG11201502781PA (en) 2015-06-29
IL238126A0 (en) 2015-05-31
US20180125918A1 (en) 2018-05-10
KR20150067187A (ko) 2015-06-17
CN104703616A (zh) 2015-06-10
US20150258157A1 (en) 2015-09-17
BR112015007896B1 (pt) 2021-01-26
AU2013328716A1 (en) 2015-04-30
RU2646459C2 (ru) 2018-03-05
WO2014057024A1 (en) 2014-04-17
US10967033B2 (en) 2021-04-06
CA2887831A1 (en) 2014-04-17
BR112015007896A2 (pt) 2017-07-04
PT2906233T (pt) 2018-02-05

Similar Documents

Publication Publication Date Title
SI2906233T1 (sl) Farmacevtske oblike za zdravljenje in preventivo debelosti
ES2608818T3 (es) Métodos y formulaciones para convertir fármacos intravenosos e inyectables en formas de dosificación orales
CY1115652T1 (el) Μορφη δοσολογιας που περιεχει δυο δραστικα φαρμακευτικα συστατικα μειγματος σε διαφορετικες φυσικες μορφες
MX2017012878A (es) Composiciones gomosas de multicomponentes con nucleo duro.
AR110194A2 (es) Composiciones cosméticas y/o farmacéuticas y método para preparar dichas composiciones
NO20090554L (no) Farmasoytiske preparater av memantin
WO2005120158A3 (en) Herbal compositions for prevention and treatment of rheumatic and inflammatory diseases and method of preparing the same
WO2008063910A3 (en) Method of preparing solid dosage forms of multi-phasic pharmaceutical compositions
WO2007016284A3 (en) Pharmaceutical formulations/composition of guanfacine suitable for single dose form adminstration daily
GEP20156281B (en) Orally administered corticosteroid compositions
Wu et al. Ameliorative effects of arctiin from Arctium lappa on experimental glomerulonephritis in rats
WO2007020382A3 (en) Plant-based medicament for the treatment of liver disease
BRPI0508579A (pt) composto, composição farmacêutica, e, uso de um composto
Keehn et al. Complementary and alternative medications for benign prostatic hyperplasia
BRPI0418681A (pt) um suplemento dietético para o tratamento e a prevenção de doenças do sistema digestivo e doenças relacionadas ao sistema digestivo e método de produção e administração deste
WO2019141802A1 (fr) Extrait obtenu a partir de plusieurs plantes pour son utilisation dans la prevention et/ou le traitement des maladies chroniques inflammatoires de l'intestin
JP2018527305A5 (sl)
BR112016026667A8 (pt) comprimido oralmente desintegrante para administração de avanafil, métodos associados de fabricação e uso de um inibidor de pde v
WO2007131070A3 (en) Compositions, dosage forms and methods of treating emesis
WO2008075320A3 (en) Antilipidemic pharmaceutical compositions and process for preparation thereof
Sharma et al. Distribution and phytomedicinal aspects of Paris polyphylla Smith from the Eastern Himalayan Region: A review
WO2007120838A3 (en) Rapidly disintegrating solid oral dosage form of liquid dispersions
JP2016501862A5 (sl)
HRP20160774T1 (hr) Pripravci za liječenje umora povezanog s karcinomom
Sindhu et al. Evaluation of phenolic contents and antioxidant potential of Murraya Koenigii (L) spreng roots